The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition

Author:

Fleischman Angela G.12,Maxson Julia E.12,Luty Samuel B.12,Agarwal Anupriya1,Royer Lacey R.12,Abel Melissa L.12,MacManiman Jason D.12,Loriaux Marc M.12,Druker Brian J.123,Tyner Jeffrey W.124

Affiliation:

1. Division of Hematology & Medical Oncology,

2. Knight Cancer Institute,

3. Howard Hughes Medical Institute, and

4. Department of Cell & Developmental Biology, Oregon Health & Science University, Portland, OR

Abstract

Key Points CSF3R T618I is sufficient to drive a lethal myeloproliferative disease in a mouse bone marrow transplant model. Treatment of CSF3R T618I mice with the JAK1/2 inhibitor ruxolitinib effectively reduces white blood cell count and spleen size.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3